(Total Views: 726)
Posted On: 10/16/2020 2:13:11 AM
Post# of 153860
The PR is written unduly neutral in nature, with no cheerleading. One of the posters on IHub gave me this thought: https://investorshub.advfn.com/boards/read_ms...=158933155
He refers to it as written benign without any fluff.
The Philippines PR had a similar feel to me.
It's like something is purposefully being left out of these PR's. Written matter of fact, in a legalize manner.
Kind of written like the warning labels on the side of a medication bottle.
Also, doesn't mention doctors (except Dr. Jay) will be there. No fillers are mentioned, except for a slide show, which presumably has to do with the topic at hand. No mention of additional indications for the drug being on the agenda.
It seems to be solely about "the recommendations of the [DSMC] . . . for patients with severe-to-critical COVID-19 indications, including a potential regulatory path forward."
He refers to it as written benign without any fluff.
The Philippines PR had a similar feel to me.
It's like something is purposefully being left out of these PR's. Written matter of fact, in a legalize manner.
Kind of written like the warning labels on the side of a medication bottle.
Also, doesn't mention doctors (except Dr. Jay) will be there. No fillers are mentioned, except for a slide show, which presumably has to do with the topic at hand. No mention of additional indications for the drug being on the agenda.
It seems to be solely about "the recommendations of the [DSMC] . . . for patients with severe-to-critical COVID-19 indications, including a potential regulatory path forward."
(2)
(0)
